The COVID-19 epidemic in Madagascar : clinical description and laboratory results of the first wave, march-september 2020
© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd..
BACKGROUND: Following the first detection of SARS-CoV-2 in passengers arriving from Europe on 19 March 2020, Madagascar took several mitigation measures to limit the spread of the virus in the country.
METHODS: Nasopharyngeal and/or oropharyngeal swabs were collected from travellers to Madagascar, suspected SARS-CoV-2 cases and contact of confirmed cases. Swabs were tested at the national reference laboratory using real-time RT-PCR. Data collected from patients were entered in an electronic database for subsequent statistical analysis. All distribution of laboratory-confirmed cases were mapped, and six genomes of viruses were fully sequenced.
RESULTS: Overall, 26,415 individuals were tested for SARS-CoV-2 between 18 March and 18 September 2020, of whom 21.0% (5,553/26,145) returned positive. Among laboratory-confirmed SARS-CoV-2-positive patients, the median age was 39 years (IQR: 28-52), and 56.6% (3,311/5,553) were asymptomatic at the time of sampling. The probability of testing positive increased with age with the highest adjusted odds ratio of 2.2 [95% CI: 1.9-2.5] for individuals aged 49 years and more. Viral strains sequenced belong to clades 19A, 20A and 20B indicative of several independent introduction of viruses.
CONCLUSIONS: Our study describes the first wave of the COVID-19 in Madagascar. Despite early strategies in place Madagascar could not avoid the introduction and spread of the virus. More studies are needed to estimate the true burden of disease and make public health recommendations for a better preparation to another wave.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Influenza and other respiratory viruses - 15(2021), 4 vom: 15. Juli, Seite 457-468 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 18.06.2021 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/irv.12845 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321465202 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321465202 | ||
| 003 | DE-627 | ||
| 005 | 20240402232510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/irv.12845 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1360.xml |
| 035 | |a (DE-627)NLM321465202 | ||
| 035 | |a (NLM)33586912 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Randremanana, Rindra Vatosoa |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The COVID-19 epidemic in Madagascar |b clinical description and laboratory results of the first wave, march-september 2020 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.06.2021 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Following the first detection of SARS-CoV-2 in passengers arriving from Europe on 19 March 2020, Madagascar took several mitigation measures to limit the spread of the virus in the country | ||
| 520 | |a METHODS: Nasopharyngeal and/or oropharyngeal swabs were collected from travellers to Madagascar, suspected SARS-CoV-2 cases and contact of confirmed cases. Swabs were tested at the national reference laboratory using real-time RT-PCR. Data collected from patients were entered in an electronic database for subsequent statistical analysis. All distribution of laboratory-confirmed cases were mapped, and six genomes of viruses were fully sequenced | ||
| 520 | |a RESULTS: Overall, 26,415 individuals were tested for SARS-CoV-2 between 18 March and 18 September 2020, of whom 21.0% (5,553/26,145) returned positive. Among laboratory-confirmed SARS-CoV-2-positive patients, the median age was 39 years (IQR: 28-52), and 56.6% (3,311/5,553) were asymptomatic at the time of sampling. The probability of testing positive increased with age with the highest adjusted odds ratio of 2.2 [95% CI: 1.9-2.5] for individuals aged 49 years and more. Viral strains sequenced belong to clades 19A, 20A and 20B indicative of several independent introduction of viruses | ||
| 520 | |a CONCLUSIONS: Our study describes the first wave of the COVID-19 in Madagascar. Despite early strategies in place Madagascar could not avoid the introduction and spread of the virus. More studies are needed to estimate the true burden of disease and make public health recommendations for a better preparation to another wave | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Surveillance | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a madagascar | |
| 650 | 4 | |a pandemic | |
| 700 | 1 | |a Andriamandimby, Soa-Fy |e verfasserin |4 aut | |
| 700 | 1 | |a Rakotondramanga, Jean Marius |e verfasserin |4 aut | |
| 700 | 1 | |a Razanajatovo, Norosoa Harline |e verfasserin |4 aut | |
| 700 | 1 | |a Mangahasimbola, Reziky Tiandraza |e verfasserin |4 aut | |
| 700 | 1 | |a Randriambolamanantsoa, Tsiry Hasina |e verfasserin |4 aut | |
| 700 | 1 | |a Ranaivoson, Hafaliana Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Rabemananjara, Harinirina Aina |e verfasserin |4 aut | |
| 700 | 1 | |a Razanajatovo, Iony |e verfasserin |4 aut | |
| 700 | 1 | |a Razafindratsimandresy, Richter |e verfasserin |4 aut | |
| 700 | 1 | |a Rabarison, Joelinotahiana Hasina |e verfasserin |4 aut | |
| 700 | 1 | |a Brook, Cara E |e verfasserin |4 aut | |
| 700 | 1 | |a Rakotomanana, Fanjasoa |e verfasserin |4 aut | |
| 700 | 1 | |a Rabetombosoa, Roger Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Razafimanjato, Helisoa |e verfasserin |4 aut | |
| 700 | 1 | |a Ahyong, Vida |e verfasserin |4 aut | |
| 700 | 1 | |a Raharinosy, Vololoniaina |e verfasserin |4 aut | |
| 700 | 1 | |a Raharimanga, Vaomalala |e verfasserin |4 aut | |
| 700 | 1 | |a Raharinantoanina, Sandratana Jonhson |e verfasserin |4 aut | |
| 700 | 1 | |a Randrianarisoa, Mirella Malala |e verfasserin |4 aut | |
| 700 | 1 | |a Bernardson, Barivola |e verfasserin |4 aut | |
| 700 | 1 | |a Randrianasolo, Laurence |e verfasserin |4 aut | |
| 700 | 1 | |a Randriamampionona, Léa Bricette Nirina |e verfasserin |4 aut | |
| 700 | 1 | |a Tato, Cristina M |e verfasserin |4 aut | |
| 700 | 1 | |a DeRisi, Joseph L |e verfasserin |4 aut | |
| 700 | 1 | |a Dussart, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Vololoniaina, Manuela Christophère |e verfasserin |4 aut | |
| 700 | 1 | |a Randriatsarafara, Fidiniaina Mamy |e verfasserin |4 aut | |
| 700 | 1 | |a Randriamanantany, Zely Arivelo |e verfasserin |4 aut | |
| 700 | 1 | |a Heraud, Jean-Michel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Influenza and other respiratory viruses |d 2007 |g 15(2021), 4 vom: 15. Juli, Seite 457-468 |w (DE-627)NLM176605215 |x 1750-2659 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:4 |g day:15 |g month:07 |g pages:457-468 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/irv.12845 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 4 |b 15 |c 07 |h 457-468 | ||